Articles tagged with "ACR Convergence 2021 – RA"

Insights into JAK Inhibitor Use

January 20, 2022 • By Michele B. Kaufman, PharmD, BCGP

New Findings on COVID-19 Vaccination, Race & More Shared in 1st Plenary Session

December 9, 2021 • By Thomas R. Collins

Does Switching from IV to Subcutaneous Tocilizumab Affect RA Disease Flare?

December 9, 2021 • By Michele B. Kaufman, PharmD, BCGP

Updates on JAK Inhibitor Safety, COVID-19 Vaccination in Immunosuppressed Patients & More

December 7, 2021 • By Jeffrey Curtis, MD, MS, MPH

Management of Adults with JIA: Uveitis, MAS & More

December 2, 2021 • By Mary Beth Nierengarten

What Orthopedists Want Rheumatologists to Know: Surgical Treatment for Foot & Ankle Arthritis

December 2, 2021 • By Mary Beth Nierengarten

Heart to Heart: Cardiovascular Disease in Autoimmune Conditions

December 2, 2021 • By Jason Liebowitz, MD

FDA Discussed 2021 Drug Warnings & Approvals at ACR Annual Meeting

December 1, 2021 • By Thomas R. Collins

Joint Venture: 2021 Updates in Rheumatoid Arthritis

November 24, 2021 • By Jason Liebowitz, MD

Clinical Rheumatology Year in Review 2021

November 22, 2021 • By Samantha C. Shapiro, MD